πŸ‡ΊπŸ‡Έ FDA
Patent

US 10092583

Imidazopyridines Syk inhibitors

granted A61KA61K31/437A61K31/444

Quick answer

US patent 10092583 (Imidazopyridines Syk inhibitors) held by GILEAD CONNECTICUT, INC. expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GILEAD CONNECTICUT, INC.
Grant date
Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/437, A61K31/444, A61K31/4545, A61K31/496